Trial Profile
A retrospective trial evaluating the efficacy and safety of Onabotulinumtoxina in elderly patients with overactive bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2016 New trial record
- 16 Sep 2016 Efficacy and safety results (n=24) presented at the 46th Annual Meeting of the International Continence Society.